Newsfeed

Holistic Approach Helps Patients Engage in Care
Recent advances and clinical research have shown that better care for people with pulmonary arterial hypertension (PAH) can lead to longer lives. But recently the focus has shifted from treatment options that improve the functional aspects of the disease alone to including care that improves overall quality of life and the ability to perform day-to-day activities. A review published in the European Respiratory Review (https://www.ncbi.nlm.nih.gov…
Adcirca Shown Effective for Pediatric Patients with PAH in Clinical Practice in Japan
Adcirca (tadalafil) showed an acceptable safety profile and effectiveness in a real-world clinical cohort of pediatric patients with pulmonary arterial hypertension (PAH) in Japan.
Doctors Are Doing Inadequate Job of Screening Scleroderma Patients for PAH, Study Concludes
Scientists have long known that people with scleroderma are at increased risk of developing pulmonary arterial hypertension. But many with scleroderma whom doctors suspect of having PAH are not receiving optimal screening for the respiratory condition, a study concludes. Nor are enough scleroderma patients suspected of having pulmonary hypertension being referred for tests that would confirm the condition.
Anges Québec leads $us 9 million financing round for innovative medical technology
Anges Québec announced a major investment in 4C Medical Technologies Inc., a company developing minimally invasive therapies for structural heart disease.
Breathing in a New Gene Therapy to treat Pulmonary Hypertension
Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the lungs that is linked to heart failure. If the therapy succeeds in human clinical trials, it will provide patients for the first time with a way to reverse the damage caused by PH
Positive Interim Results Of Aironite Phase 2 Study Presented At 4th Annual Drug Discovery And Development Symposium For Pulmonary Hypertension
Aironite Significantly Lowered Pulmonary Artery Pressures and Significantly Increased Pulmonary Arterial Compliance
Teenage girl undergoes first combined heart-lung transplant
Giving a big leap to organ transplant surgeries in the two Telugu States, Yashoda Hospitals, Secunderabad, performed the first-ever combined heart-lung transplantation surgery on a single person simultaneously.
SSc Patients with PAH Show High Levels of Adipsin in the Blood, Study Reports
Systemic sclerosis (SSc) patients with pulmonary arterial hypertension (PAH) show high serum levels of adipsin, a peptide secreted from adipose tissue. Researchers believe adipsin could be used as a potential biomarker for SSc-PAH in these people.
In Memory of Harry Kingston, PHA Canada Director
It is with great sadness that we share news of the passing of PHA Canada Director Harry Kingston. Harry passed away peacefully on Tuesday, June 27th, in Ottawa, Ontario, with his wife Teri by his side. Our thoughts go out to her, and to Harry’s step-children (Danielle and Marc), family, and friends.
In Memory of Lynn-Marie Cox, PHA Canada Director
It is with great sadness that we share news of the passing of PHA Canada Director – and long-term PAH survivor­­ – Lynn-Marie (Lynn) Cox. Lynn passed away on Friday, June 23rd in Edmonton, AB surrounded by her family. Our thoughts go out to her husband (Brian), sons (Robert and Andrew), and granddaughter (Madison).
Recent News

Subscribe

Get the latest on PH treatments, community events and more when you subscribe to our newsletter

ImagineCan_Accreditation_Trustmark_ENGFR_WHT-FNL_white.png